PR

Paul Rennie

CEO

Paradigm Biopharmaceuticals

Melbourne, Victoria


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Paradigm Biopharmaceuticals
Industry
pharmaceuticals
Employees
22.0
Seniority
C suite

Technologies

Route 53 Outlook MailChimp SPF Amazon AWS Salesforce WordPress.org YouTube Vimeo Adobe Media Optimizer Cedexis Radar Mobile Friendly Apache reCAPTCHA Google Font API Google Tag Manager

Keywords

pharmaceutical manufacturing drug development injectable pentosan polysulfate sodium osteoarthritis treatment mucopolysaccharidosis clinical trials disease modifying potential regulatory pathways clinical efficacy transforming underutilised molecules fda approved drugs pain management chronic disease therapies inflammation reduction preclinical studies healthcare innovations pharmaceutical commercialization biopharmaceutical research investor opportunities clinical trial recruitment global disease treatment safety profiles commercialization strategies investor relations syndromic treatments therapeutic approaches repurposing drugs clinical outcomes development pipeline nutraceutical options veterinary applications market performance analyst reports peer-reviewed publications clinical study design patient-focused treatments chronic pain solutions genetic & rare diseases emerging drug therapies health technology assessment medical safety assessments impact studies novel drug formulations clinical research networks disease biomarkers science-driven approach global health partnership commercial development healthcare access pathways pharmaceuticals medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans